Modeling of human GLE1 mutations in mice to understand RNA metabolism in vivo

Description of the granted funding

It has become evident that abnormalities in RNA processing play a fundamental role in multiple human pathologies. This research concentrates on proving new information of biological and pathological functions of multifunctional GLE1 protein, which mediates RNA transport in mammalian cells. I aim at doing this by modeling human GLE1-deficiency, known as lethal congenital contracture syndrome 1 (LCCS1), in mice to facilitate understanding of RNA metabolism in development, physiology, and disease. LCCS1 is a rare embryonic lethal syndrome of the Finnish disease heritage, which causes motoneuron defects but is poorly studied in vivo. The results of my studies tackle not only rare LCCS1 but are also translatable to common diseases with RNA transport contribution, such as Alzheimer's and Parkinson's disease, which are incurable and cause a huge challenge in sustainable health.
Show more

Starting year

2022

End year

2025

Granted funding

Tomas Zarybnicky Orcid -palvelun logo
297 703 €

Funder

Research Council of Finland

Funding instrument

Postdoctoral Researcher

Decision maker

Scientific Council for Biosciences, Health and the Environment
28.04.2022

Other information

Funding decision number

348906

Fields of science

Genetics, developmental biology, physiology

Research fields

Kehitysbiologia ja fysiologia

Identified topics

genes, genetics